pentobarbital will decrease the extent or outcome of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Stay away from coadministration of bedaquiline with robust CYP3A4 inducers as a result of prospective for decreased therapeutic outcomepentobarbital will lower the extent or impact of atogepant by… Read More